This account traces that arc: the growth hormone-releasing peptide (GHRP) tradition that made ipamorelin conceivable, its characterization at Novo Nordisk in 1998, the 1999 identification of ghrelin that redefined its target, the preclinical program that broadened its research profile, and the clinical and regulatory milestones that followed
What should you drink on Ozempic
Green et al., 2006
Why GLP-1 weight-loss plateaus occur: Clinical insights
36,39 The existing data suggest that although it may have a favorable cosmetic outcome, issues of recurrence and histological confirmation have not been adequately addressed
Consistent sleep and wake times, a cool dark bedroom, limiting alcohol, avoiding caffeine after midday, and managing stress are the most consistently evidence-supported sleep hygiene strategies